About MicrofluidX
MicrofluidX is a company based in London (United Kingdom) founded in 2018 by Antoine Espinet and Cesare Cejas. It operates as a D2C. MicrofluidX has raised $13.14 million across 6 funding rounds from investors including Esco Lifesciences, UK Research and Innovation and Cambridge Angels. The company has 10 employees as of March 31, 2022. MicrofluidX offers products and services including Cyto Engine. MicrofluidX operates in a competitive market with competitors including Unibio, Univercells Tech, Nirrin Technologies, Pow.Bio and Caladan Bio, among others.
- Headquarter London, United Kingdom
- Employees 10 as on 31 Mar, 2022
- Founders Antoine Espinet, Cesare Cejas
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Microfluidx Ltd
- Date of Incorporation 25 Oct, 2018
- Jurisdiction STEVENAGE, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.14 M (USD)
in 6 rounds
-
Latest Funding Round
$867.61 K (USD), Grant
Dec 19, 2023
-
Investors
Esco Lifesciences
& 8 more
-
Employee Count
10
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MicrofluidX
MicrofluidX offers a comprehensive portfolio of products and services, including Cyto Engine. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tool for cell analysis updates via website
Unlock access to complete
Funding Insights of MicrofluidX
MicrofluidX has successfully raised a total of $13.14M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $867.61 thousand completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $867,614
-
First Round
First Round
(09 Apr 2020)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Grant - MicrofluidX | Valuation |
investors |
|
| Oct, 2023 | Amount | Seed - MicrofluidX | Valuation |
investors |
|
| Dec, 2022 | Amount | Series A - MicrofluidX | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MicrofluidX
MicrofluidX has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Esco Lifesciences, UK Research and Innovation and Cambridge Angels. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage deeptech businesses are supported through venture capital investments.
|
Founded Year | Domain | Location | |
|
Early-stage innovations are funded by UKI2S across key sectors.
|
Founded Year | Domain | Location | |
|
Seed to growth stage investments focused venture capital and private equity firm based out of London
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MicrofluidX
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MicrofluidX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Microfluidx Comparisons
Competitors of MicrofluidX
MicrofluidX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unibio, Univercells Tech, Nirrin Technologies, Pow.Bio and Caladan Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Animal feed supplements are produced using proprietary fermentation technology.
|
|
| domain | founded_year | HQ Location |
Intensified biomanufacturing technologies for viral production are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Developer of sensor and integration technologies for continuous control and bioprocess automation
|
|
| domain | founded_year | HQ Location |
Intelligent fermentation services for industrial and synthetic biology are provided.
|
|
| domain | founded_year | HQ Location |
Modular bioreactors are developed for biotechnology research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about MicrofluidX
When was MicrofluidX founded?
MicrofluidX was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is MicrofluidX located?
MicrofluidX is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of MicrofluidX?
Antoine Espinet is the current CEO of MicrofluidX. They have also founded this company.
Is MicrofluidX a funded company?
MicrofluidX is a funded company, having raised a total of $13.14M across 6 funding rounds to date. The company's 1st funding round was a Series A of $4.02M, raised on Apr 09, 2020.
How many employees does MicrofluidX have?
As of Mar 31, 2022, the latest employee count at MicrofluidX is 10.
What does MicrofluidX do?
MFX, previously MicrofluidX, is a company registered in England and Wales that focuses on providing updates for the Cyto Engine, likely a tool for cell analysis in biotech. They have rebranded and direct users to their new website for the latest information. The company engages in digital content delivery and maintains all rights reserved as of 2024, emphasizing innovation in healthcare tech.
Who are the top competitors of MicrofluidX?
MicrofluidX's top competitors include Unibio, Univercells Tech and Nirrin Technologies.
What products or services does MicrofluidX offer?
MicrofluidX offers Cyto Engine.
Who are MicrofluidX's investors?
MicrofluidX has 9 investors. Key investors include Esco Lifesciences, UK Research and Innovation, Cambridge Angels, Longwall Ventures, and UKI2S.